Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Ringworm Disease: Market Insight Epidemiology , Forecast , Prevention, Redefining Market Entry Strategies, & Disrupting Competitive intelligences by Disease Landscape Insights


News provided by

Disease Landscape Insights

13 Sep, 2023, 14:10 GMT

Share this article

Share toX

Share this article

Share toX

Disease Landscape Insights equips healthcare pioneers with the tools to combat ringworm early stages, providing in-depth diagnostic, treatment, and market insights. Although ringworm is a common fungal infection, it can be particularly troublesome due to its ability to affect various parts of the body. DLI's Healthcare Consulting Services play a vital role in streamlining the process of conducting Clinical Trial Assessment for new ringworm treatments and medications, contributing to aspects such as patient recruitment strategies and regulatory consulting.

LONDON, Sept. 13, 2023 /PRNewswire/ -- Ringworm Disease, despite its misleading name, is a common fungal infection that affects the skin, nails, and occasionally the scalp. To effectively combat this troublesome condition, it's essential to understand how to diagnose, treat, and manage it. In this article, we will explore the various diagnostic and treatment options available for ringworm in cats and how Disease Landscape Insights, a healthcare and pharma consulting services company, can assist at every step.

Diagnostic Analysis

Diagnosing ringworm accurately is the crucial first step toward effective 3 day ringworm treatment. Traditional diagnostic techniques are the backbone of this process.

Conventional Diagnostic Techniques

Healthcare providers often rely on their expertise to visually inspect and diagnose ringworm based on characteristic symptoms. These symptoms include a red, circular rash with raised edges and itching. However, visual diagnosis alone may not provide information about the specific type of fungus causing the infection or its severity.

Solutions for Dermatophytosis

Dermatophytosis, the medical term for ring worms, can be challenging to identify definitively without additional diagnostic tools.

Microscopic Examination Dependent Techniques

Microscopic examination involves collecting a sample from the affected area and studying it under a microscope. This method allows healthcare professionals to visualize fungal elements such as hyphae or spores. While it aids in confirming the presence of fungus, it may not always provide information about the precise type or severity of the infection.

Price and Market Access

Modified Rapid Culturing Techniques

To gain a more detailed understanding of the fungus responsible for the infection, modified rapid culturing techniques are employed. A sample is taken from the affected area and cultured in a controlled environment to encourage fungal growth. This approach helps in identifying the specific species of the fungus and assessing its severity.

Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF) Based Techniques

In cases where traditional methods fall short, advanced techniques like MALDI-TOF mass spectrometry come into play. This cutting-edge technology analyzes the protein profiles of fungal samples, allowing for precise identification of the fungus responsible. It's a game-changer in diagnosing and understanding ringworm infections.

Molecular Diagnostic Techniques

Molecular diagnostic techniques involve studying the genetic material of the fungus. By analyzing the DNA, healthcare professionals can pinpoint the exact species of the fungus and gain valuable insights into its virulence and resistance patterns.

Therapeutic Analysis

Once the diagnosis is confirmed, the next step is ringworm treatment at home. Effective therapeutic analysis is crucial to ensure a swift recovery.

Over-the-Counter Antifungals

For mild cases of ringworm on leg, over-the-counter antifungal creams and ointments are often sufficient. They work by targeting and eradicating the fungus, alleviating symptoms and promoting healing.

In more severe or persistent cases, healthcare providers may prescribe stronger antifungal medications. These can be administered orally or topically, depending on the location and extent of the infection. DLI helps in Product Portfolio Analysis further narrowing down the process.

Learn More About the FDA NDA & BLA Approval (NME) Drugs for Psoriasis Disease @ https://www.diseaselandscape.com/requestsample/postid/67

The Market Landscape for Ringworm Disease

Unveiling Key Players and Innovations in Ringworm Treatment

The ringworm disease market hosts a variety of global players offering effective antifungal medications. Additionally, promising innovations are in development that could revolutionize the market. For example, Blueberry Therapeutics is currently advancing Terbinafine Hydrochloride in Phase 2, a potentially game-changing therapy for ringworm. This breakthrough holds promise for highly efficient ringworm treatment for humans, paving the way for enhanced patient care.

Furthermore, Viamet Pharmaceuticals is conducting phase 2 clinical trials for osteoseconzole to treat onychomycosis. The progress observed in these trials reflects the industry's commitment to improving patient outcomes and underscores the potential for innovation in this field.

According to the World Health Organization (WHO), Dermatophytosis affects 25% of the global population, with 30 to 70% of individuals experiencing asymptomatic conditions. Approximately 20-25% of people worldwide are affected by ringworm on people. This high prevalence is attributed to increased migration, tourism, and interactions with ringworm-infected animals.

Clinical Trial Assessment

In some instances, conventional treatments may not yield the desired results. This is where clinical trials come into play.

Clinical Trial Assessment

Clinical trials are research studies designed to test new treatments or therapies for various medical conditions, including ringworm rash. Participating in a clinical trial can provide access to cutting-edge treatments and contribute to advancing medical knowledge.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @
https://www.diseaselandscape.com/checkout?report_id=67

The ongoing ringworm clinical trials are:

PHASE 1 (Human Pharmacology)

PHASE 2 (Therapeutic Exploratory Trail)

PHASE 3 (Therapeutic Confirmatory Trial)

PHASE 4 (Post Marketing Surveillance)

An Open Label, Parallel Group Comparison Study to Evaluate the Safety Tolerability and Pharmacokinetics of UHE-103 Cream Versus Naftin Cream in Subjects with Tinea Cruris and/or Tinea Pedis Under Maximal Use Conditions

An Open-Label Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Hallux Terbinafine Subungual Gel Administered to the Toenail Bed of Patients with Distal-Lateral Subungual Onychomycosis

A Multi-center, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)


Pilot Study to Determine the Safety and Efficacy of Regimen Frequencies Using the Swift Microwave Device for Mild to Moderate Toenail Onychomycosis Caused by Dermatophytes

Pilot Study to Determine the Safety and Efficacy of Regimen Frequencies Using the Swift Microwave Device for Mild to Moderate Toenail Onychomycosis Caused by Dermatophytes



A Phase 1, First in Human, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATB1651 in Adults with Mild to Moderate Onychomycosis




DLI: Your Partner in Healthcare and Pharma

DLI, a trusted healthcare consulting and pharma consulting company, plays a pivotal role in supporting healthcare providers and pharmaceutical companies in the battle against ringworm stages. Here's how DLI can assist:

Advanced Diagnostic Solutions: DLI offers access to state-of-the-art Disease insights and Drug Insights, including MALDI-TOF mass spectrometry and molecular diagnostic techniques. These tools aid in accurate diagnosis and better understanding of ringworm on foot infections.

Treatment Strategy: DLI with its Ringworm Disease Overview collaborates with healthcare providers to develop tailored treatment strategies. With a deep understanding of the latest therapeutic options, DLI ensures patients receive the most effective treatments available.

Clinical Trial Support: DLI facilitates clinical trial assessments and Drug Development, connecting patients with opportunities to participate in studies exploring innovative ringworm treatments for cats. Their expertise streamlines the process, ensuring patient safety and compliance.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @ https://www.diseaselandscape.com/downloadsample/postid/67

Last Words

Ringworm may be a common fungal infection, but its diagnosis and treatment require precision and expertise. With DLI as your Pricing and Market Access partner, you can access advanced diagnostic tools, personalized treatment plans, and the opportunity to contribute to cutting-edge research. Together, we can better understand, treat, and ultimately conquer ringworm on leg.

Search more about Infectious Diseases

Related Reports: 

Exploring Solid Tumor Epidemiology: Studies, Market Size, and Forecasts 

Global Landscape of Lung Cancer Services: Insights and Trends 

Pneumonia Demystified: Symptoms, Causes, and Prevention Strategies 

Demodex Blepharitis: How to Achieve Eye Health and Eliminate Demodex 

Understanding Lupus: Navigating the Complex Autoimmune Disorder 

Comprehensive Guide to Ringworm: Symptoms, Causes, and Effective Treatment 

Alzheimer's Disease Uncovered: Symptoms, Diagnosis, and Treatment Insights 

Parkinson's Disease Explored: Symptoms, Causes, and Treatment Breakthroughs 

Comprehensive Guide to Diverticulitis: Symptoms, Causes, and Solutions 

Revolutionizing Healthcare: Harnessing AI-Powered Predictive Analytics 

The Role of AI in Medical Imaging: Revolutionizing Healthcare 

AI-Driven Personalized Medicine: Ethics and Responsibility 

Ethical Considerations in AI Healthcare Solutions: Balancing Innovation and Responsibility 

Advancements in Natural Language Processing (NLP) for Healthcare 

Exploring the Leading Causes of Cancer Deaths: Identifying Deadly Contributors 

Inpefa by Lexicon Pharmaceuticals: A Breakthrough in Medical Innovation 

Empowering Hope: Paxlovid - A COVID-19 Breakthrough Treatment 

Posluma: Advancing Prostate Cancer Imaging in Targeted Oncology 

Xacduro by Innoviva Specialty Therapeutics: Empowering Bacterial Pneumonia Treatment

About Disease Landscape: 

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods. 

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research. 

Contact Us:
Disease Landscape Insights LLP
6th Floor, Sr No.207, Office A H 6070 Phase 1
Solitaire Business Hub, Viman Nagar
Pune, Maharashtra, 411014
Email: ajay@diseaselandscape.com   
Email: vishal@diseaselandscape.com
Corporate Sales: +44-2038074155 
Asia Office: +917447409162
Blog: https://www.diseaselandscape.com/blogs
Case Study: https://www.diseaselandscape.com/casestudies  
Pharma consulting Services

Follow Us: LinkedIn | Twitter | Facebook 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.